New drug RBD5044 aims to lower high triglycerides in phase 2 trial

NCT ID NCT07587788

Recruiting now Disease control Sponsor: Ribotek Biopharmaceuticals (Shandong) Co., Ltd Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This Phase 2 trial tests whether the drug RBD5044 can safely lower high triglyceride levels in adults. About 40 Chinese participants with high triglycerides will receive either RBD5044 or a placebo twice over 84 days. The main goal is to see if RBD5044 reduces triglyceride levels compared to placebo.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: RBD5044
What this could lead to: If it works, this could lead to a new treatment option for people with high triglycerides, helping reduce heart disease risk.
What could go wrong: This is an early Phase 2 trial with only 40 participants, so results may not apply to everyone. The drug may not lower triglycerides better than placebo, and side effects are unknown.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HYPERTRIGLYCERIDEMIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

hypertriglyceridemia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HYPERTRIGLYCERIDEMIA

Contacts and locations

Locations

Daqing People's Hospital
RECRUITING

Daqing, Heilongjiang, China
Jingzhou Central Hospital
RECRUITING

Jingzhou, Hubei, China
Lishui Central Hospital
RECRUITING

Lishui, Zhejiang, China
Peking University First Hospital
RECRUITING

Beijing, China
The First Affiliated Hospital of Henan University of Science and Technology
RECRUITING

Luoyang, Henan, China
The First Affiliated Hospital of Nanyang Medical College
RECRUITING

Nanyang, Nanyang, China
The Fourth Hospital of Harbin Medical University
RECRUITING

Harbin, Heilongjiang, China
Yuncheng Central Hospital
RECRUITING

Yuncheng, Shanxi, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.